René M M van Aerts

Clinical management of polycystic liver disease.

J. Drenth, J. Banales, René M M van Aerts, 2017, Journal of hepatology.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial

J. D. de Fijter, J. Wetzels, R. Zietse, 2018, JAMA.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

J. D. de Fijter, J. Wetzels, R. Zietse, 2019, Gastroenterology.

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

F. Nevens, J. Drenth, T. Gevers, 2018, Therapeutic advances in gastroenterology.

Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry

F. Nevens, C. Ahn, J. Reiterová, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis.

René M M van Aerts, G. Koek, C. Van Deursen, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial

J. D. de Fijter, J. Wetzels, R. Zietse, 2018, JAMA.